Bio-Rad Labs

For more information, visit http://www.bio-rad.com/CheckoutPrecis... For a primary antibody to be selected as a PrecisionAb Antibody, it must be highly specific, highly sensitive, and pass a rigorous validation process that includes consistent performance from batch to batch. Out of throusands of primary antibodies screened, only a few are admitted into the elite PrecisionAb Antibody category.

Try PrecisionAb Antibodies and see how you can generate reproducible data without wasting time and resources on optimization. 

PrecisionAb Validated Western Blotting Antibodies offer researchers 
• High specificity and sensitivity – selected for low nonspecific binding, correct target molecular weight, and the strongest signal on a western blot 
• Reproducible results – stringent QC requirements ensure consistent lot-to-lot performance 
• Trial size for every antibody (2 applications) - conveniently evaluate western blot performance 
• Confidence in your data – positive control lysate provided for each antibody; validation protocol included 

We Are Bio-Rad. 

Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges. 

Connect with Bio-Rad Antibodies Online: 
Website: https://www.bio-rad-antibodies.com/ 
LinkedIn: https://www.linkedin.com/showcase/bio... 
Facebook: https://www.facebook.com/BioRadAntibo... 
Twitter: https://twitter.com/BioRadAbs 
Pinterest: https://www.pinterest.com/BioRadAbs/ 
Instagram: @BioRadLabs 
Snapchat: @BioRadLabs

How Does an Antibody Become a PrecisionAb™ Antibody?

For more information, visit https://www.bio-rad-antibodies.com/precisionab-western-blotting-antibodies.html?utm_source=youtube&utm_medium=social&utm_campaign=PrecisionAb%20surlhearyou

We hear you! PrecisionAb™ Validated Western Blotting Antibodies are our solution to the current pain points of many protein scientists looking for high-quality, trustworthy antibodies to detect their protein of interest with minimal optimization. Explore the PrecisionAb Antibody selection and see for yourself how you can benefit from using PrecisionAb Antibodies. 

PrecisionAb Validated Western Blotting Antibodies offer researchers 
• High specificity and sensitivity – selected for low nonspecific binding, correct target molecular weight, and the strongest signal on a western blot 
• Reproducible results – stringent QC requirements ensure consistent lot-to-lot performance 
• Trial size for every antibody (2 applications) - conveniently evaluate western blot performance 
• Confidence in your data – positive control lysate provided for each antibody; validation protocol included 

We Are Bio-Rad. 

Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges. 


Resolve Your Western Blotting Woes with Better Antibodies

We have developed the PrecisionAb Antibody line with a lot of care and pride. These are premium-quality antibodies extensively validated for western blotting. They can work in other applications as well with user-optimized conditions. We offer them as a powerful set of tools to enhance and empower any protein scientist's arsenal.

PrecisionAb Validated Western Blotting Antibodies offer researchers
• High specificity and sensitivity – selected for low nonspecific binding, correct target molecular weight, and the strongest signal on a western blot
• Reproducible results – stringent QC requirements ensure consistent lot-to-lot performance
• Trial size for every antibody (2 applications) - conveniently evaluate western blot performance
• Confidence in your data – positive control lysate provided for each antibody; validation protocol included

PrecisionAb™ Antibodies- Enhance Your Western Blotting Toolbox

Watch this video to see how PrecisionAb Validated Western Blotting Antibodies are defining a new standard of quality that you can trust to deliver superior results and reproducibility in western blotting.
The lack of high-quality primary antibodies has been a constant challenge for scientists across different areas of research. To address this need, Bio-Rad has introduced PrecisionAb Western Blot Validated primary antibodies. We hand-selected a collection of highly sensitive and specific antibodies to enable scientists to obtain dependable western blotting data without trial and error. 
Each PrecisionAb Antibody is tested against whole-cell lysates (up to 12 cell lines) expressing proteins at endogenous levels. Western blots are run by a group of scientists who scrutinize the data based on comparison against relevant bioinformatic database references, signal-to-background ratio, and other parameters.
Only those antibodies meeting the standards for all criteria are released as PrecisionAb Antibodies. The results are high-performing antibodies that exhibit the highest levels of specificity and sensitivity, yielding great performance in western blotting applications. 
For more information, visit http://www.bio-rad.com/PrecisionAbInfo

Western Blotting without Trial and Error- Use PrecisionAb™ Antibodies

Researchers at Chronix Biomedical applied Bio-Rad's ddPCR[trade/] technology to quantify graft-derived cell-free DNA (cfDNA) in recent liver transplant patients and in stable patients who had undergone a transplant procedure more than six months earlier. ddPCR technology allowed Chronix to develop a fast and cost-effective laboratory test to detect cfDNA released into the blood stream by dying cells from the transplanted organ. Sequencing methods typically require batch sampling, but using ddPCR assays, researchers are able to run single samples. Additionally, this method reduces test time from three days or more to one day, and reduces costs by 90 percent. The study authors were able to address the need for donor DNA by preselecting single-nucleotide polymorphisms (SNPs) that ensure enough heterogeneity between donor and recipient. The new blood test can also deliver results up to several days earlier than the conventional aspartate aminotransferase (AST) and bilirubin tests for liver transplantation rejection, with the potential for an immediate positive impact on patient care. Chronix Biomedical is a molecular diagnostics company developing blood tests primarily for cancer, including companion diagnostics and tests for detecting minimal residual disease. Chronix is preparing to offer its pioneering tests through its own laboratories under CLIA certification in North America and the CE mark in Europe. The Company's initial product is a test to be used by cancer treatment centers and oncologists in the treatment of breast cancer patients. Chronix is privately held with headquarters in San Jose, California, and laboratories in Göttingen, Germany and Brookings, South Dakota. The Droplet Digital PCR system enables the quantification of target DNA with unrivaled precision by partitioning samples into 20,000 nanoliter-sized droplets. After PCR on a thermal cycler, PCR-positive and PCR-negative droplets are counted to provide absolute quantification of the target DNA. The QX200[trade/] system, Bio-Rad's second-generation digital PCR system, provides absolute quantification of target DNA or RNA molecules using EvaGreen or TaqMan hydrolysis probes, yielding unmatched sensitivity and precision for a wide variety of applications.

Bio-Rad Labs

Home

Videos

Playlists

About

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.